Overview Fundamentals API Earnings EOD API Sample Code Pricing

Regeneron Pharmaceuticals Inc (REGN NASDAQ) stock market data APIs

$1056 -4.86(-0.5%) as of July 24, 2024
Price chart is built with Anychart

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Regeneron Pharmaceuticals Inc Financial Data Overview

1060.86
1056
-
1066.4301
1052.8101
723.56-1106.16
116 309 M
31.1561
108 M
13 100 M
9.55
0.128
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'REGN',
Type: 'Common Stock',
Name: 'Regeneron Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000C734W3',
ISIN: NULL,
CUSIP: NULL,
CIK: '872589',
EmployerIdNumber: '13-3444607',
FiscalYearEnd: 'December',
IPODate: '1991-04-02',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Regeneron Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 13 100 M
  • EBITDA 4 425 M
  • Earnings Per Share 33.88
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Regeneron Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast 10.09

Get Regeneron Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com